BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10486797)

  • 1. Provider attitudes and self-reported behaviors related to hormone replacement therapy.
    Rolnick SJ; Kopher RA; Compo RB; Kelley ME; DeFor TA
    Menopause; 1999; 6(3):257-63. PubMed ID: 10486797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of multiple providers for regular care and women's receipt of hormone replacement therapy counseling.
    Gallagher TC; Geling O; Comite F
    Med Care; 2001 Oct; 39(10):1086-96. PubMed ID: 11567171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What factors account for hormone replacement therapy prescribing frequency?
    Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
    Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician gender and hormone replacement therapy discussion.
    Huston S; Sleath B; Rubin RH
    J Womens Health Gend Based Med; 2001 Apr; 10(3):279-87. PubMed ID: 11389788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider management of menopause after the findings of the Women's Health Initiative.
    Rolnick SJ; Jackson J; Kopher R; Defor TA
    Menopause; 2007; 14(3 Pt 1):441-9. PubMed ID: 17318028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden.
    Nilsen ST; Pedersen AT; Moen MH; Milsom I; Mattsson LA; Iversen OE; Larsen PM; Andersson K
    Maturitas; 2001 Jul; 39(1):83-90. PubMed ID: 11451625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause.
    Kaplan B; Aschkenazi-Steinberg S; Yogev Y; Nahum R; Sulkes J; Phisher M
    Menopause; 2002; 9(5):354-9. PubMed ID: 12218724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines-a survey in Sweden.
    Halldorsdottir S; Dahlstrand H; Stålberg K
    Ups J Med Sci; 2018 Dec; 123(4):225-229. PubMed ID: 30526173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy after treatment for breast cancer: physicians' attitudes towards randomized trials.
    Del Giudice ME; Sawka CA; Pritchard KI; Llewellyn-Thomas HA; Trudeau ME; Lewis JE; Franssen E
    Breast Cancer Res Treat; 2003 May; 79(2):213-23. PubMed ID: 12825856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
    Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
    J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency contraception provision: a survey of Michigan physicians from five medical specialties.
    Xu X; Vahratian A; Patel DA; McRee AL; Ransom SB
    J Womens Health (Larchmt); 2007 May; 16(4):489-98. PubMed ID: 17521252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
    Rodriguez MA; Bauer HM; McLoughlin E; Grumbach K
    JAMA; 1999 Aug; 282(5):468-74. PubMed ID: 10442663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency contraception: prescribing practices of general internists compared with other primary care physicians.
    Chuang CH; Waldman LJ; Freund KM; Ash AS
    Contraception; 2004 Jan; 69(1):43-5. PubMed ID: 14720619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion of breast cancer risk assessment in primary care.
    Guerra CE; Sherman M; Armstrong K
    J Am Board Fam Med; 2009; 22(3):272-9. PubMed ID: 19429733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussion of hormone replacement therapy between physicians and their patients.
    Schneider AE; Davis RB; Phillips RS
    Am J Med Qual; 2000; 15(4):143-7. PubMed ID: 10948786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider attributes associated with hormone therapy prescribing frequency.
    Spangler L; Reed SD; Nekhyludov L; Grothaus LC; LaCroix AZ; Newton KM
    Menopause; 2009; 16(4):810-16. PubMed ID: 19407679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and practices of Korean gynecologists towards hormone replacement therapy in endometrial cancer survivors.
    Lee SJ; Yeo SG; Kang SB; Park DC
    Eur J Gynaecol Oncol; 2013; 34(6):513-7. PubMed ID: 24601041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent patterns of hormone replacement therapy use in a large managed care organization.
    Whitlock EP; Johnson RE; Vogt TM
    J Womens Health; 1998 Oct; 7(8):1017-26. PubMed ID: 9812298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.
    Persell SD; Zei C; Cameron KA; Zielinski M; Lloyd-Jones DM
    Arch Intern Med; 2010 Mar; 170(5):470-7. PubMed ID: 20212185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
    Shafi S; Samad Z; Syed S; Sharif A; Khan MA; Nehal US; Siddiqui AR
    J Pak Med Assoc; 2001 Dec; 51(12):450-3. PubMed ID: 11850984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.